Boehringer Hit With New OT Action Over Sales Reps
On the heels of an appeals court ruling that drug sales representatives aren't exempt from overtime pay under the Fair Labor Standards Act, Boehringer Ingelheim Pharmaceuticals Inc. is facing another putative...To view the full article, register now.
Already a subscriber? Click here to view full article